中国奥星医药公司最近报道完成了可待因磷酸盐的注册试验。可待因是一种可治疗急性中度到重度咳嗽的口服制剂。
China Aoxing Pharmaceutical Company reported that it has completed the registration trial of Codeine Phosphate, an oral solution that treats acute moderate to severe cough.
中国奥星医药公司最近报道完成了可待因磷酸盐的注册试验。可待因是一种可治疗急性中度到重度咳嗽的口服制剂。
China Aoxing Pharmaceutical Company reported that it has completed the registration trial of Codeine Phosphate, an oral solution that treats acute moderate to severe cough.
应用推荐